Compare RITM & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RITM | SHC |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | 6045 | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.4B |
| IPO Year | N/A | 2020 |
| Metric | RITM | SHC |
|---|---|---|
| Price | $10.17 | $15.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $14.06 | ★ $20.33 |
| AVG Volume (30 Days) | ★ 7.2M | 2.6M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 9.83% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | N/A | $7.51 |
| Revenue Next Year | $28.68 | $6.00 |
| P/E Ratio | ★ $10.21 | $59.11 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $8.43 | $10.68 |
| 52 Week High | $12.74 | $19.85 |
| Indicator | RITM | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 60.11 | 54.50 |
| Support Level | $9.41 | $15.19 |
| Resistance Level | $11.24 | $16.55 |
| Average True Range (ATR) | 0.21 | 0.40 |
| MACD | 0.07 | 0.15 |
| Stochastic Oscillator | 89.60 | 54.81 |
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.